CRISPR successfully cuts a single gene from cancer cells of head and neck tumors

Written by Lucy Welsh (Digital Editor)
Head and neck News Targeted therapies

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.

Researchers from Tel Aviv University (Israel), led by Razan Masarwy, have investigated utilizing CRISPR in lipid nanoparticle (LNP) delivery systems to target cancer-specific genes in head and neck cancers. By cutting out an essential cancer gene, 50% of tumors were successfully eliminated from in vivo mouse models, indicating the potential of targeted CRISPR-LNP delivery systems for cancer treatment.

Read More On BioTechniques

Source

  1. Masarwy R, Breier D, Stotsky-Oterin L et al. Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer. Adv. Sci. 12(7), e2411032 (2024).